
Immortals Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: Bryan Johnson's longevity brand: compounded microdose GLP-1 from $167/mo
Price is where Immortals scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Immortals’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose weekly injections. Every subscription includes physician review within 72 hours, prescription fulfillment from licensed U.S. pharmacies, discreet shipping, and unlimited provider messaging for 12 months. Personalized-dose semaglutide starts at $157/month and tirzepatide at $217/month, and microdose tiers at $167 and $180 (billed quarterly). HSA/FSA reimbursable; no insurance required.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Immortals
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Immortals at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $157/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Immortals
Each dimension is scored algorithmically from Immortals’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $157/mo, Immortals runs about 12% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.0/10Immortals offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.0/10Immortals's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10Immortals provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Immortals review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $157–$217/mo across 2 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Immortals
We walked Immortals’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Answer a few quick questions in the online quiz to get matched with an option.
- 2A physician reviews every recommendation.
- 3There is no charge until your prescription is approved.
- 4Create an account/dashboard to manage your treatment.
- Offers personalized semaglutide and tirzepatide plus branded Wegovy and Zepbound.
- Homepage shows a promotional 'Start Now - $1 / Day*' CTA (asterisked), but no actual monthly medication price is displayed before intake.
- No charge is stated until a prescription is approved.
- A refund policy link exists in the footer but terms are not disclosed.
- No support phone, email, or hours are visible on the read pages.
GLP-1 medications Immortals offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Immortals offers
Beyond GLP-1s, Immortals also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Same price at every dose, billed quarterly with a three-month commitment paid up front. A microdose tier is $167 (regular $245). Brand Wegovy is $1,550.
Same price at every dose, billed quarterly with a three-month commitment paid up front. A microdose tier is $180 (regular $265). Brand Zepbound is $600.
Ready to get started?
Plans and promotions change often, so check Immortals's current pricing and active discounts before you decide.
What we like
- LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
- Physician consult + prescription bundled in price ("You pay for treatment. That's it") with no added fees
- Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
- Unlimited provider messaging for 12 months included; video consults available
- Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)
Watch-outs
- Microdose framing uses sub-clinical doses, which means lower weight-loss efficacy than standard GLP-1 protocols
- Quarterly commitment only: 3-month minimum, paid upfront ($501–$540/quarter), with no monthly flexibility
- State availability not publicly listed; 'eligible U.S. states' with no specific state list
- Labs not included; baseline bloodwork protocol not disclosed on any public page
- Compounding pharmacy not named; no 503A/503B accreditation details disclosed
Is Immortals worth it?
The short version of what Immortals offers is Bryan Johnson's longevity brand: compounded microdose GLP-1 from $167/mo. It runs $157/month, toward the affordable end of the category, so cost isn't the reason to look elsewhere. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Immortals offers a microdosing option. It also is LegitScript-certified and offers B12 add-ons.
How much Immortals costs
Compounded semaglutide runs $157/month and compounded tirzepatide runs $217/month.
That puts Immortals below the roughly $179 median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide), which is a cost advantage you can count on.
bmiMD (about $159/month) is one of the closest alternatives to weigh Immortals against.
Medications: what Immortals prescribes
Immortals prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who Immortals is best for, and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost: $157/month is below the roughly $179 median we track across the category (each program's lowest listed ongoing monthly price).
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Immortals earns its place on the shortlist mainly on price: at $157/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight. To see Immortals against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Price is where Immortals scores best in our breakdown.
Ready to start with Immortals?
From $157/mo. See current pricing and start your free consultation.
Immortals might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Immortals vs…
Immortals scores7.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
Immortals vs Amazon One Medical
Amazon One Medical scores 8.5/10

Immortals vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Immortals review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Immortals's current pricing
Plans from $157/mo. Start your free consultation to check eligibility and today's price.